Catalyst Wire Dossier Catalyst Wire Dossier

VR647 inhalation suspension

· Vectura Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VR647 inhalation suspension, covering 2019-10-21 to 2019-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma [Phase 1]

See pricing